Effect of age on the incidence of acute hepatitis b after 25 years of a universal newborn hepatitis B immunization program in Taiwan

Journal of Infectious Diseases

Volumn 205, Issue 5, 2012, Pages 757-762

  Su, Wei Ju ^a,b,c   Liu, Cheng Chung ^a   Liu, Ding Ping ^a   Chen, Shu Fong ^a   Huang, Ji Jia ^b   Chan, Ta Chien ^b   Chang, Mei Hwei ^c  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ACUTE HEPATITIS; ADOLESCENT; ADULT; AGE; ARTICLE; BIRTH; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SURVEILLANCE; HEPATITIS B; HUMAN; IMMUNIZATION; INFANT; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MORBIDITY; NEWBORN CARE; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RISK FACTOR; TAIWAN; VACCINATION; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; HEPATITIS B; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; POISSON DISTRIBUTION; POPULATION SURVEILLANCE; TAIWAN; VACCINATION; YOUNG ADULT;

EID: 84863146656     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir852     Document Type: Article

References (22)

1. Kao JH, Chen DS. Universal hepatitis B vaccination: killing 2 birds with 1 stone. Am J Med 2008; 121:1029-31.
2. Wasley A, Miller JT, Finelli L. Surveillance for acute viral hepatitis-United States, 2005. MMWR Surveill Summ 2007; 56:1-24.
3. Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006; 28:126-35.
4. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336: 1855-9.
5. Chang MH. Hepatitis B vaccination: disease and cancer preventionda Taiwanese experience. Clin Liver Dis 2010; 14:521-30.
6. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2:395-403.
7. Chang MH, You SL, Chen CJ, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009; 101:1348-55.
8. Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001; 139:349-52.
9. Lu CY, Ni YH, Chiang BL, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 2008; 197:1419-26.
10. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000; 355:561-5.
11. Mele A, Stroffolini T, Zanetti AR. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. J Med Virol 2002; 67:440-3.
12. Taiwan Centers for Disease Control. Guidelines for notifiable communicable diseases surveillance. http://www.cdc.gov.tw/public/Data/ 1291174171.pdf. Accessed 18 February 2011.
13. Jeng WJ, Sheen IS, Liaw YF. Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B. Clin Gastroenterol Hepatol 2010; 8:541-5.
14. Huang YW, Lin CL, Chen PJ, Lai MY, Kao JH, Chen DS. Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B. J Gastroenterol Hepatol 2006; 21:859-62.
15. Davis GL, Hoofnagle JH. Reactivation of chronic type B hepatitis presenting as acute viral hepatitis. Ann Intern Med 1985; 102: 762-5. (Pubitemid 15062573)
16. Da Villa G, Romano L, Sepe A, et al. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine 2007; 25:3133-6. (Pubitemid 46482751)
17. La Torre G, Nicolotti N, de Waure C, et al. An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy. Virol J 2008; 5:84.
18. Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data-United States. MMWR Morb Mortal Wkly Rep 2011; 60: 410-13.
19. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults. MMWR Recomm Rep 2006; 55:1-33; quiz CE1-4.
20. Yogeswaran K, Fung SK. Chronic hepatitis B in pregnancy: unique challenges and opportunities. Korean J Hepatol 2011; 17:1-8.
21. Centers for Disease Control and Prevention (CDC). Acute hepatitis B among children and adolescentsdUnited States, 1990-2002. MMWR Morb Mortal Wkly Rep 2004; 53:1015-18.
22. Mele A, Tosti ME, Mariano A, et al. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 2008; 46: 868-75. (Pubitemid 351417188)